Effectiveness of a Standardized Healthcare Education Program in People With Heart Failure
Heart failure is a chronic illness with a high prevalence and impact on the quality of life of the people who experience it, associated with high hospital taxes and mortality. Beyond the results of traditional clinics, factors such as health literacy, therapeutic adherence and self-healing play a key role in the evolution of this pathology. Various studies show that inadequate health literacy levels lead to better control of malaria, more re-entry and a lower quality of life.
The objective of this research is to evaluate the effectiveness of a standard health education care program, led by nurses specialized in heart failure, initiating discharge from hospitals and with structured follow-up during the first few months afterward, compared to conventional care. It is intended to analyze its impact on health literacy, therapeutic adherence, self-healing, and quality of life, as well as explore the associated social determinants.
It will last a random clinical trial between two groups (intervention and control) at the Heart Failure Unit of the Figueres Hospital. The participants will be adults admitted for decompensation of heart failure and will be followed for 12 months, with evaluations at admission, at 6 months and at any time after discharge. It is important to serve validated instruments to measure quality of life, health literacy and therapeutic adherence.
It is hoped that the intervention will improve the quality of life and health literacy of people with heart failure, contributing to more equitable care, centered on the person and oriented towards better health outcomes.
Descripción general del estudio
Estado
Estado
Condiciones
Condiciones
Intervención / Tratamiento
Intervención / Tratamiento
Tipo de estudio
Tipo de estudio
Inscripción (Estimado)
Inscripción
Fase
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
Estudio Contacto
- Nombre: Clara Vargas Farber, RN Nurse
- Número de teléfono: +34972592005
- Correo electrónico: cvargas@salutemporda.cat
Copia de seguridad de contactos de estudio
- Nombre: Silvia Zuheros Santó, Administrative
- Correo electrónico: szuheros@salutemporda.cat
Criterios de participación
Criterio de elegibilidad
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- People who are admitted for decompensated heart failure, and who are going to undergo post-discharge monitoring at the Heart Failure Unit of the Figueres Hospital.
- have signed the informed consent.
Exclusion Criteria:
- People diagnosed with cognitive impairment or dementia.
- Institutionalized people.
- Foreign people or people who live outside the hospital's reference area.
- People with language difficulties.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Prevención
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Número de brazos
Armas e Intervenciones
Grupo de participantes/brazoGrupo de participantes/brazo |
Intervención / TratamientoIntervención / Tratamiento |
|---|---|
|
Experimental: Educational group
In the case of the intervention group, a standardized, structured and more intense follow-up plan than usual will be applied. |
This next step will begin after discharge from the hospital with a face-to-face visit from specialized nursing, in which a comprehensive assessment will be carried out, the administration of measurement scales, individualized health education and coordination of primary care and other assistance devices if necessary. |
|
Sin intervención: control group
usual nursing care |
¿Qué mide el estudio?
Medidas de resultado primarias
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Number of patients with nursing intervention who need hospital admission in a year
Periodo de tiempo: From enrollment to the end of treatment at 12 months
|
Review of the patient's medical history at the annual visit to see how many times they have been admitted for heart failure decompensation. The number of admissions, the main admission diagnosis, and the number of days in the hospital will be reviewed |
From enrollment to the end of treatment at 12 months
|
|
Number of visits to the emergency room in the past year for patients who have undergone the nursing intervention
Periodo de tiempo: From enrollment to the end of treatment at 12 months
|
Review of the patient's medical history at the annual visit to see the number of emergency visits for heart failure decompensation. The number of visits to the emergency room, the reason for the visit, the main diagnosis at discharge, and the patient's destination will be checked |
From enrollment to the end of treatment at 12 months
|
Medidas de resultado secundarias
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Number of people with a good level of self-care according to the scale Self-Care of Heart Failure Index who have received intervention from the nurse
Periodo de tiempo: From enrollment to the end of treatment at 12 months
|
The questionnaire consists of 22 items spread across three independent scales that assess the patient's behaviors over the past month. The items are answered using a four-point Likert scale. The scores for each scale are calculated separately and converted into standardized values from 0 to 100, where higher scores indicate a better level of self-care. A score of 70 or above is considered indicative of adequate self-care. |
From enrollment to the end of treatment at 12 months
|
Colaboradores e Investigadores
Patrocinador
Patrocinador
Investigadores
Investigadores
- Director de estudio: Maria Rosa Suñer Soler, RN, PhD, Universitat de Girona
- Silla de estudio: Aurora Fontova Almató, RN, PhD, Fundacio Salut Emporda
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Estimado)
Inicio del estudio
Finalización primaria (Estimado)
Finalización primaria
Finalización del estudio (Estimado)
Finalización del estudio
Fechas de registro del estudio
Enviado por primera vez
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Publicado por primera vez
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización publicada
Última actualización enviada que cumplió con los criterios de control de calidad
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
Otros números de identificación del estudio
- 2026.145
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
It is a single-center study that does not intend to share information with third parties and will only publish the research results.
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .